NCT06090318 2023-10-19Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A LossRain Oncology IncPhase 1/2 Withdrawn
NCT00588263 2018-02-19Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have CancerMemorial Sloan Kettering Cancer CenterWithdrawn